角膜移植术后组织相关不良事件的纵向趋势
基于美国一家大型眼库2007年5月至2024年12月的126072份供体角膜组织数据,研究分析了角膜移植相关组织不良事件(AE)的纵向趋势。组织相关AE的估计患病率为0.14%(95%CI:0.12%-0.16%),每年AE的比值降低6.7%(95%CI:3.8%-9.5%,P<.001),17年间估计降低69.2%。与PKP相比,调整年份后DSAEK和DMEK的AE比值分别为2.3倍和2.8倍,但改善趋势无显著差异;感染性角膜炎和原发性移植物失败率逐年显著改善。
要点
- 组织相关AE总体患病率为0.14%(95%CI:0.12%-0.16%)。
- AE比值每年降低6.7%(95%CI:3.8%-9.5%,P<.001),17年估计降低69.2%。
- DSAEK和DMEK的AE比值高于PKP,但改善趋势无显著差异。
核心结论
- 角膜移植手术的AE率逐年下降,反映眼库和角膜移植安全性与质量持续改善。
- 改善见于PKP、DMEK和DSAEK各术式,以及感染性角膜炎和移植物失败等AE类型。
研究设计与样本
- 趋势研究,数据来自美国一家大型眼库2007年5月至2024年12月的数据库。
- 共纳入126072份供体角膜组织,分析外科医生报告的眼库AE及判定为组织相关原因的AE。
主要发现
- 组织相关AE共176例,估计患病率0.14%(95%CI:0.12%-0.16%)。
- 每年AE比值降低6.7%(95%CI:3.8%-9.5%,P<.001),17年估计降低69.2%。
- 调整年份后,DSAEK的AE比值是PKP的2.3倍(95%CI:1.6-3.2,P<.001),DMEK是PKP的2.8倍(95%CI:1.8-4.5,P<.001)。
- PKP至DSAEK(P=.6)或PKP至DMEK(P=.4)的改善率无显著差异。
- 感染性角膜炎(OR:0.91,95%CI:0.83-0.99,P=.024)和原发性移植物失败(OR:0.90,95%CI:0.86-0.94,P<.001)逐年显著改善,眼内炎(P=.13)和早期再移植(P=.3)无显著改善。
临床怎么用
- 眼库和临床医生可参考AE类型与术式的纵向趋势,评估组织移植风险。
- 尽管DSAEK和DMEK的AE比值高于PKP,但各术式AE率均随时间改善。
局限性
- 数据来自单一美国眼库,外推需谨慎。
- AE依赖外科医生报告,可能存在报告偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The longitudinal trend of tissue-related adverse events (AEs) from corneal transplant procedures is not well characterized. By identifying corneal transplantation-related AEs over time, eye banks and clinicians can better understand changes and assess the risks associated with tissue transplantation. DESIGN: Trend study. SUBJECTS: Corneal tissues obtained from individuals who donated to Eversight Eye Bank. METHODS: This study investigated the rates of reported AEs at a large eye bank in the United States. Data was extracted from the eye bank database between May 2007 and December 2024. A longitudinal analysis of AEs in corneal tissue was conducted across AE types and procedural types. MAIN OUTCOME MEASURES: The main outcome measures were surgeon-reported AEs to the eye bank and AEs determined to be tissue-related causes. AE types for tissue-related AEs were assessed. RESULTS: A total of 126,072 donor tissues were included between May 2007 and December 2024. 176 AEs were determined to be tissue-related, representing an estimated prevalence of 0.14% (95% CI: 0.12%-0.16%). For every year, there was an associated 6.7% (95% CI: 3.8%-9.5%) reduction in the odds of AEs (P < .001), an estimated 69.2% reduction over 17 years. Adjusted for year, Descemet stripping automated endothelial keratoplasty (EK) (DSAEK) had 2.3 times (95% CI: 1.6-3.2, P < .001) and Descemet membrane EK (DMEK) had a 2.8 (95% CI: 1.8-4.5, P < .001) odds of AE compared to PKP, but no significant difference in the rate of improvement for PKP to DSAEK (P = .6) or PKP to DMEK (P = .4). Rates of infectious keratitis (OR: 0.91, 95% CI: 0.83-0.99, P = .024) and primary graft failure (OR: 0.90, 95% CI: 0.86-0.94, P < .001) significantly improved year-over-year, while endophthalmitis (P = .13) and early regraft (P = .3) did not significantly improve. CONCLUSIONS: AE rates in corneal transplantation procedures continue to decline year-over-year, highlighting the improving safety and quality in eye banking and corneal transplantation. Rates improved across procedure types (PKP, DMEK, and DSAEK) and AEs (infectious keratitis and graft failure).
引用
- Reddy K, Dmitriev PM, Hurlbert S, et al. Longitudinal Trends in Tissue-Related Adverse Events After Corneal Transplantation. Am J Ophthalmol. 2026. PMID: 41951199. doi:10.1016/j.ajo.2026.03.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。